The second season of the Merative MarketScan podcast has commenced, with its inaugural episode delving into the intricate and often…
Read More

The second season of the Merative MarketScan podcast has commenced, with its inaugural episode delving into the intricate and often…
Read More
Scientists at the University of Edinburgh have unveiled promising results from the MATCH clinical trial, demonstrating the potential of a…
Read More
The pharmaceutical industry’s financial landscape underwent a significant reordering in fiscal year 2025, as revealed by the latest "Pharma 50"…
Read More
The US Food and Drug Administration (FDA) has granted a pivotal approval for Datroway (datopotamab deruxtecan), a novel antibody-drug conjugate…
Read More
The fiscal year 2025 closed with a dramatic reshuffling at the pinnacle of the pharmaceutical industry’s sales leaderboard, signaling profound…
Read More
The first quarter of 2024 has concluded, leaving a landscape reshaped by evolving market dynamics, groundbreaking therapeutic advancements, and persistent…
Read More
A groundbreaking strategic partnership has been announced between OpenBench, a pioneer in AI-driven drug discovery, and Concept Life Sciences, a…
Read More
Gilead Sciences has officially completed its acquisition of Tubulis, a prominent German biotechnology firm specializing in the development of next-generation…
Read More
Today’s pharmaceutical landscape is characterized by drug development programs that routinely span continents, involving distributed research teams, multinational clinical trial…
Read More
New data released by Europe’s leading infectious disease agency reveals a concerning decade-high surge in bacterial sexually transmitted infections (STIs),…
Read More